SHERWIN STEPHEN A - Insider Transactions
Insider Type
individual
Companies
2
Average
2,755,543
Total Txns
4
Long-Term
Annual Transaction Insights
Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
---|---|---|---|---|---|---|
2024 | 0 | 2 | -2 | 0.00 | 5,338,564.50 | -5,338,564.50 |
2025 | 0 | 2 | -2 | 0.00 | 2,928,064.70 | -2,928,064.70 |
Total: | 0 | 4 | 4 | 0.00 | 8,266,629.20 | -8,266,629.20 |
Transactions
Company | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Biogen Inc. Common Stock US09062X1037 |
150.02 USD |
8,760 Sold |
1,314,142 USD |
07/03/2025 | 07/03/2025 |
Neurocrine Biosciences, Inc. Common Stock US64125C1099 |
116.69 USD |
13,831 Sold |
1,613,923 USD |
13/02/2025 | 13/02/2025 |
Neurocrine Biosciences, Inc. Common Stock US64125C1099 |
133.46 USD |
25,000 Sold |
3,336,555 USD |
29/05/2024 | 29/05/2024 |
Neurocrine Biosciences, Inc. Common Stock US64125C1099 |
133.47 USD |
15,000 Sold |
2,002,010 USD |
29/05/2024 | 29/05/2024 |